UGenome
  • Home
    • 1-minute UGenome overview
  • About
    • UGenome in the News
    • About
    • Contact
    • Team
    • Advisors
    • Partners & Collaborators
    • UGenome’s Mission, Vision, Values
    • UGenome Policies October 2025
    • Investors
  • Genomic Software
  • Bioinformatics
    • Bioinformatics Services
    • Bioinformatics Case Studies
  • Medication Response Solutions
    • UGenome’s PGx Case Studies
    • Emerging Trends
    • Rare Disease & Women’s Health Resources
    • Dictionary
Select Page

Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics

by Brooks | Jul 6, 2025 | Clinical outcomes, Emerging Trends, Next generation sequencing, Pharmacogenomics, Reduce Adverse Drug Reactions

Jennifer Tovar, PharmD & Husna Rahim, PharmD Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics. How has Next Generation Sequencing (NGS) transformed the field of pharmacogenomics (PGx)? NGS, also known as massive parallel sequencing, is...

Recent Posts

  • Could Genetic Biomarkers Transform Kidney Disease Treatment?  
  • How Do National Genome Projects Advance the Power of Pharmacogenomics? 
  • How can Pharmacogenomics Protect Older Adults from the Risks of Polypharmacy?
  • Can Genetic Insights Refine Arrhythmia Treatment?
  • Pharmacogenomics, Nutrigenomics, and Longevity

Recent Comments

No comments to show.

UGenome Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

Sign up for UGenome's Newsletter on LinkedIn!

 

Click Here
Website built by The Free Website Guys 🚀
  • Follow
  • Follow